Study platform for solid organ cancers
Part of Cancer clinical trials.
This study looks at people who have had a standard-of-care biopsy or surgical tissue removal for a solid organ cancer. The goal is to test how treatment options work based on the information from those tissue samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a biopsy or surgery to remove a tissue sample as part of your usual care.
- You are able and willing to provide informed consent (or have a legally authorized person to consent, if applicable).
- You are not a child or adolescent (pediatric patients are not included).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples from your cancer (like during surgery or a biopsy) to grow tiny lab “organoids” for testing. It may help researchers learn which treatments could work better for different cancers.
This trial collects a small piece of your tumor right after it is removed during surgery. Researchers will study this tissue to learn more about cancer and how it responds to treatments.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This trial takes a small sample of your tumor to grow a model in the lab. This model helps doctors test which treatments might work best for you.
This study collects fresh samples of tumor tissue during procedures like surgery, biopsy, or TURBT to test a cancer therapy outside the body. It may help researchers learn which treatments work better for different solid cancers.
This trial collects tissue (samples) from people who are already scheduled for biopsy or surgery for certain solid cancers. It aims to improve future testing and research while checking that taking the sample is safe and doesn’t add extra risk.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.